Skip to main content
# Title Research Year
21 The transcription factor ZEB-1 conveys chemoresistance in breast cancer 2024
22 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt 2023
23 FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients 2023
24 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy 2023
25 Prognostic Effect of Nodular and Infiltrating Tumor deposits of colorectal carcinoma and its relation to neoadjuvant therapy a retrospective study 2023
26 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma 2023
27 Signet ring cell component predicts the response to neoadjuvant chemoradiotherapy in rectal cancer. Long interim results of a single institution experience 2022
28 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents 2021
29 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents 2021
30 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents 2021